James H B Im
Overview
Explore the profile of James H B Im including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chow R, Im J, Arends J, Del Fabbro E, Mortensen-Truscott L, Qeska D, et al.
BMJ Support Palliat Care
. 2025 Jan;
PMID: 39890439
Background: The aim of this systematic review and meta-analysis is to compare the complication rates of enteral nutrition (EN) (oral or tube feeding (TF)) and parenteral nutrition (PN) in patients...
2.
Im J, Wahi G, Giglia L, Bayliss A, Kanani R, Pound C, et al.
Hosp Pediatr
. 2024 Jan;
14(2):67-74.
PMID: 38164101
Objectives: To examine 2 hospital oxygen saturation target policies and clinical outcomes in infants hospitalized with bronchiolitis. Methods: This multicenter cohort study used data collected from a randomized clinical trial...
3.
Im J, Trope G, Buys Y, Yan P, Brent M, Liu S, et al.
CMAJ Open
. 2023 Dec;
11(6):E1125-E1134.
PMID: 38052477
Background: Diabetes, a leading cause of visual impairment, is on the rise in Canada. We assessed trends in the prevalence of visual impairment among people in Canada with and without...
4.
Chow R, So O, Im J, Chapman K, Orchanian-Cheff A, Gershon A, et al.
Int J Chron Obstruct Pulmon Dis
. 2023 Nov;
18:2581-2617.
PMID: 38022828
Introduction: Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death globally and is responsible for over 3 million deaths annually. One of the factors contributing to the significant...
5.
Im J, Chow R, So O, Wu R, Gershon A
Int J Chron Obstruct Pulmon Dis
. 2023 Nov;
18:2619-2621.
PMID: 38022821
No abstract available.
6.
Chow R, Drkulec H, Im J, Tsai J, Nafees A, Kumar S, et al.
Oncologist
. 2023 Nov;
29(4):e419-e430.
PMID: 37971410
Introduction: The aim of this systematic review was to summarize the current literature on wearable technologies in oncology patients for the purpose of prognostication, treatment monitoring, and rehabilitation planning. Methods:...
7.
Khan R, Kuenzig M, Tang F, Im J, Widdifield J, McCurdy J, et al.
JAMA Netw Open
. 2023 Oct;
6(10):e2337020.
PMID: 37812417
Importance: Immune-mediated inflammatory diseases (IMIDs) and COVID-19 are independently associated with venous thromboembolisms (VTEs). Objective: To determine if individuals with IMIDs are at higher risk of VTE following COVID-19 infection...
8.
Shaffer S, Kuenzig M, Windsor J, Bitton A, Jones J, Lee K, et al.
J Can Assoc Gastroenterol
. 2023 Sep;
6(Suppl 2):S45-S54.
PMID: 37674503
Approximately one out of every 88 seniors has inflammatory bowel disease (IBD), and this is expected to increase in the future. They are more likely to have left-sided disease in...
9.
Murthy S, Kuenzig M, Windsor J, Matthews P, Tandon P, Benchimol E, et al.
J Can Assoc Gastroenterol
. 2023 Sep;
6(Suppl 2):S83-S96.
PMID: 37674502
Cancer is a major cause of morbidity and mortality among people with inflammatory bowel disease (IBD). Intestinal cancers may arise as a complication of IBD itself, while extra-intestinal cancers may...
10.
Murthy S, Weizman A, Kuenzig M, Windsor J, Kaplan G, Benchimol E, et al.
J Can Assoc Gastroenterol
. 2023 Sep;
6(Suppl 2):S97-S110.
PMID: 37674501
The therapeutic landscape for inflammatory bowel disease (IBD) has changed considerably over the past two decades, owing to the development and widespread penetration of targeted therapies, including biologics and small...